Here are a few worthy news items in the world of cancer research:

• According to researchers from the ReDO Project, Dicoflenac, a common painkiller has significant anti-cancer properties. While many NSAIDs have shown promise in preventing cancer, emerging research has demonstrated evidence that these drugs may be helpful in treating cancer. Read more about Dicoflenac in ecancermedicalscience.
• New cancer statistics released by the American Cancer Society demonstrates that cancer remains a complex health issue in the US, coming a close second to heart disease as the leading cause of death. More on the numbers in CA: A Cancer Journal of Clinicians.
• A new study of twins has found that having a twin sibling diagnosed with cancer poses an excess risk for the other twin to develop any form of cancer. The study looked at over 200,000 twin individuals in Denmark, Finland, Norway, and Sweden. The results were published in JAMA.
• A recent study by researchers at University of Missouri-Columbia shows that minority and ethnic groups are being diagnosed with colorectal cancer at younger ages and more advanced stages than non-Hispanic whites. The research team used the databases SEER and NAACCR to analyze the prevalence, stage and survival rates for colorectal cancer diagnoses in the U.S. based on race and ethnicity from 1973 to 2009. Their results were published in Cancer Medicine.